Abstract: A foreign matter detection device which detects a foreign matter in an inside of a card reader. The foreign matter detection device includes a control part which performs control for causing an imaging device provided in the inside of the card reader to image a space in the inside of the card reader, and a detection part which detects the foreign matter in the space by image analysis based on a captured image obtained by the imaging device.

Abstract: A non-contact storage medium fixing structure includes a non-contact storage medium that has a memory unit which stores predetermined information of an object to be controlled, a pair of wire connection guide members respectively provided at at least two positions on a body of the non-contact storage medium, and a wire connection member that fixes the non-contact storage medium at a predetermined position of the object to be controlled, by way of the pair of wire connection guide members.

Abstract: A non-contact storage medium fixing structure includes a non-contact storage medium that has a memory unit which stores predetermined information of an object to be controlled, a pair of wire connection guide members respectively provided at at least two positions on a body of the non-contact storage medium, and a wire connection member that fixes the non-contact storage medium at a predetermined position of the object to be controlled, by way of the pair of wire connection guide members.

Abstract: The present invention relates to the method of measuring a biological ligand (1) in a sample containing an amylase (1) derived from a higher animal. This method is characterized by employing a combination of an amylase (2) not contained in the sample and an antibody against the ligand (1) or a ligand (2) capable of reacting with the antibody and an amylase inhibitor of which inhibitory activity against the amylase (1) is stronger than that against the amylase (2). The method of the invention utilizes the emphasis of steric hindrance of the amylase (2) reaction which is carried out at the boundary between solid phase and liquid phase and the specific removal of the influence of the amylase (1) by using the above amylase inhibitor. This method is suitable as a clinical test for the determination of physiological substances and trace components in a humoral fluid such as serum.

Abstract: A method is provided which is highly sensitive and specific, and is suitable as a clinical test for the determination of physiological substances and trace components in humoral fluid. The method employs a conjugate of an enzyme capable of acting on a water-insoluble macromolecular substance and an antibody against the ligand (1) to be measured or a ligand (2) having an antigenic determinant common to one of the antigenic determinant(s) of the ligand (1). In the method of the invention, steric hindrance of the conjugate is emphasized by the enzyme reaction which is carried out at the boundary between solid phase and liquid phase.

Abstract: A method of measuring a biological ligand comprises allowing to coexist a biologically active composition comprising an immobilization phase of a particular antibody or a particular ligand and an immobilization phase of a biotinyl enzyme or a biotinyl enzyme inhibitor, a water-soluble conjugate of the ligand or the antibody and the biotinyl enzyme inhibitor or the biotinyl enzyme, and the ligand to be measured in an aqueous solution, and measuring the remaining biotinyl enzyme activity or the biotinyl enzyme inhibitory activity. This method is highly sensitive and specific, and it is suitable as a clinical test for the determination of physiological substances and trace components in humoral fluid.

Abstract: A novel amylase inhibitor, obtained from hard wheat and durum wheat by using dye ligand affinity chromatography having an inhibitory activity on human salivary amylase of less than 0.1 of the inhibitory activity on human pancreatic amylase is disclosed which is useful for measuring isoenzymes of amylase in the field of clinical tests.

Abstract: The invention relates to a method and novel reagents for detecting a ligand in a biological sample. In the method, the sample is combined with (i) an enzyme or an enzyme bound to a first macromolecular compound, (ii) substrate for the enzyme, and (iii) an antibody complex comprising anti-ligand bound to anti-enzyme and a second macromolecular compound bound to either one or both of the anti-ligand and anti-enzyme. The activity of the enzyme varies as a function of the unknown amount of ligand contained in the biological sample.

Abstract: A biologically active composition comprising an immobilized phase comprising an antigen or an antibody, and an immobilized phase comprising an enzyme, an enzyme inhibitor or activator, and a method of measuring antigen or antibody using the same. According to the method of the invention, antigen with antibody can be detected in a simple procedure and high sensitivity.

Abstract: Derivatives of dipeptide having the following general formula and their use as substrates for colorimetrically or spectrophotometrically measuring the activity of carboxypeptidase A: ##STR1## wherein X is OH in ortho or para position, or NH.sub.2 or CH.sub.

Abstract: An antibody is obtained by using as an antigen a complex of an antigen and the F(ab').sub.2 fragment of the human antibody of this antigen or an aggregate of the F(ab').sub.2 fragment of human immunoglobulin. This antibody reacts with an immune complex in a blood serum of a patient of systemic lupus erythematosus and with an immune complex in a blood serum of a patient of rheumatoid arthritis, and it does not react with an aggregated IgG. The amount of immune complex in a blood serum is easily and exactly determined by using this antibody.

Abstract: Derivatives of hippuryl-L-phenylalanine having the following general formula: ##STR1## wherein X represents OH or CH.sub.3 O useful as substrates for measuring the actively of carboxy peptidose A.

Abstract: A method for determining the activity of cholinesterase comprising the steps of:mixing a solution containing p-methoxybenzoate demethylmonooxygenase, nicotinamide adenine dinucleotide reduced form (NADH) and p-methoxybenzoyl choline cation having the following formula: ##STR1## with a liquid containing cholinesterase, measuring the decrease in absorbance of light by NADH, which is based on a consumption of NADH, and calculating the activity of cholinesterase therefrom.

Abstract: A method for determining the activity of an angiotensin-converting enzyme is disclosed comprising the steps of mixing a liquid containing (i) a synthetic substrate X-hippuryl-L-dipeptide having the formula ##STR1## wherein X represents OH, NH.sub.2 or N(CH.sub.3).sub.2, and when R.sub.1 is H, R.sub.2 is H, and when R.sub.1 is ##STR2## R.sub.2 is CH.sub.2 CH(CH.sub.3).sub.2, (ii) hippuricase and (iii) 4-aminoantipyrine, with a liquid containing an angiotensin-converting enzyme; measuring colorimetrically the concentration of the quinonimine dye which is formed by adding an oxiding agent to the above mixture; and calculating the activity of the angiotensin-converting enzyme from the concentration of the quinonimine dye.

Abstract: A standard blood filter paper for use in diagnosis of histidinemia, comprising a piece of filter paper, and a blood material infiltrated in the above filter paper containing a known concentration of histidine and at least one salt selected from the group consisting of a dithionite, a disulfite and a bisulfite. The standard blood filter paper can be preserved for a long term at -20.degree. C.

Abstract: A reference blood filter paper for measuring the concentration of methionine in the blood, comprising a piece of blood filter paper, a blood material infiltered in the blood filter paper containing a known concentration of methionine and at least one water-soluble, sulfur-containing antioxidant represented by general formula: ##STR1## where n=1 or 2.

Abstract: Method for determining the activity of the angiotensin-converting enzyme comprising the steps of:(1) mixing a liquid containing the angiotensin-converting enzyme with a reagent consisting essentially of X-hippuryl-L-histidyl-L-leucine, hippuricase, peroxidase, 4-aminoantipyrine and H.sub.2 O.sub.2, and(2) colorimetrically measuring the concentration of quinonimine dye produced in step (1).

Abstract: A quick hardening cement-asphalt composition used as a grout for a ballast-filled track structure comprising(a) 100 parts by weight of a cement composition prepared by adding to portland cement about 10 to 50% by weight of a mixture of a calcium aluminate-series mineral and calcium sulfate in a weight ratio of about 1:0.3 to 1:3; about 0.05 to 10% by weight of an inorganic salt, and about 0.05 to 3% by weight of at least one of an organic carboxylic acid, an organic hydroxycarboxylic acid and a salt thereof, and(b) about 30 to 400 parts by weight of an asphalt emulsion containing about 0.2 to 8% by weight of a polyoxyethylene alkyl phenyl ether, polyoxyethylene alkyl ether, polyoxyethylene alkyl ester, sorbitan alkyl ester, polyoxyethylene sorbitan alkyl ester or sucrose fatty acid ester nonionic emulsifier and about 0.05 to 2% by weight of a multivalent metal chloride, calculated as the multivalent metal ion.